Target intelligence / Profile preview

Integrins and extracellular matrix components (Integrins/ECM)

Target
Integrins/ECM
Molecular classification
Receptor, Cell adhesion molecule, Extracellular matrix protein
01

Overview

Integrins are a large family of heterodimeric transmembrane receptors, consisting of alpha and beta subunits, that facilitate cell-cell and cell-extracellular matrix (ECM) adhesion (Hynes, 2002, Cell). The ECM components, such as collagen, fibronectin, and laminin, serve as ligands that trigger outside-in signaling pathways regulating cell survival, proliferation, and migration (Humphries et al., 2006, Journal of Cell Science). Conversely, inside-out signaling regulates the affinity of integrins for their ligands, which is crucial for processes like platelet aggregation and leukocyte extravasation (Ley et al., 2016, Nature Reviews Immunology). In disease states, dysregulation of the integrin-ECM axis contributes to tumor metastasis, pathological angiogenesis, chronic inflammation, and fibrotic tissue buildup (Desgrosellier & Cheresh, 2010, Nature Reviews Cancer). Therapeutic strategies often involve monoclonal antibodies or small molecules designed to block specific integrin-ligand interactions, such as those targeting alpha-IIb-beta-3 for anti-thrombotic effects or alpha-4-beta-7 for inflammatory bowel disease (Coller, 2001, JCI).

Other names
Cell adhesion moleculesECM-receptor interactionIntegrin-ligand complexAdhesion receptors
02

Mechanism of action

Inhibition of integrin-mediated cell adhesion and signaling by blocking the interaction between integrin receptors and their extracellular matrix ligands (e.g., fibrinogen, fibronectin, or VCAM-1) (Ley et al., 2016, Nature Reviews Immunology).

03

Biological functions

Cell adhesionSignal transductionCell migrationTissue remodelingMechanotransduction
04

Disease associations

CancerInflammationFibrosisCardiovascular diseaseAutoimmune disease
05

Safety considerations

Increased risk of bleedingProgressive multifocal leukoencephalopathy (PML)Infection riskImpaired wound healing
06

Interacting drugs

Abciximab

7 more in the full profile.

07

Biomarkers

Integrin alpha-V beta-3 expressionSoluble VCAM-1Collagen degradation products (e.g., CTX-I)Fibronectin levels

Beyond the preview

Go deeper on Integrins and extracellular matrix components (Integrins/ECM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Integrins and extracellular matrix components (Integrins/ECM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call